DNA Brands, Inc. Logo

DNA Brands, Inc.

DNAX

(1.5)
Stock Price

0,00 USD

-367.3% ROA

27.69% ROE

-0.08x PER

Market Cap.

171.816,00 USD

-81.31% DER

0% Yield

0% NPM

DNA Brands, Inc. Stock Analysis

DNA Brands, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

DNA Brands, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (-0x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (-83%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 ROE

ROE in an average range (11.74%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

5 ROA

The stock's ROA (-11284.79%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

DNA Brands, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

DNA Brands, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

DNA Brands, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

DNA Brands, Inc. Revenue
Year Revenue Growth
2007 0
2008 35.825 100%
2009 6.214 -476.52%
2010 1.168.461 99.47%
2011 1.191.688 1.95%
2012 249.416 -377.79%
2013 156.803 -59.06%
2015 5.372 -2818.89%
2016 0 0%
2017 0 0%
2017 0 0%
2018 0 0%
2019 18.068 100%
2020 249.013 92.74%
2021 459.334 45.79%
2022 0 0%
2023 0 0%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

DNA Brands, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

DNA Brands, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 0
2008 0 0%
2009 27.962 100%
2010 6.718.984 99.58%
2011 3.643.739 -84.4%
2012 3.457.512 -5.39%
2013 2.260.410 -52.96%
2015 234.376 -864.44%
2016 247.137 5.16%
2017 614.508 59.78%
2017 314.875 -95.16%
2018 256.515 -22.75%
2019 193.629 -32.48%
2020 449.678 56.94%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

DNA Brands, Inc. EBITDA
Year EBITDA Growth
2007 -47.850
2008 -15.867 -201.57%
2009 -25.890 38.71%
2010 -7.325.964 99.65%
2011 -4.295.220 -70.56%
2012 -3.585.973 -19.78%
2013 -2.454.025 -46.13%
2015 -470.639 -421.42%
2016 -247.137 -90.44%
2017 -614.508 59.78%
2017 -314.880 -95.16%
2018 -205.452 -53.26%
2019 -175.560 -17.03%
2020 -1.239.670 85.84%
2021 -300.400 -312.67%
2022 -337.590 11.02%
2023 -290.690 -16.13%
2024 -252.400 -15.17%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

DNA Brands, Inc. Gross Profit
Year Gross Profit Growth
2007 0
2008 35.825 100%
2009 6.214 -476.52%
2010 299.387 97.92%
2011 391.648 23.56%
2012 72.013 -443.86%
2013 -19.572 467.94%
2015 -53.130 63.16%
2016 0 0%
2017 0 0%
2017 0 0%
2018 0 0%
2019 19 100%
2020 250 92.4%
2021 455.802 99.95%
2022 0 0%
2023 0 0%
2024 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

DNA Brands, Inc. Net Profit
Year Net Profit Growth
2007 -48.355
2008 -18.488 -161.55%
2009 -35.906 48.51%
2010 -7.468.422 99.52%
2011 -4.472.848 -66.97%
2012 -4.444.344 -0.64%
2013 -3.100.763 -43.33%
2015 -104.373 -2870.85%
2016 -247.137 57.77%
2017 -614.508 59.78%
2017 -314.875 -95.16%
2018 -622.915 49.45%
2019 -180.621 -244.87%
2020 -1.245.472 85.5%
2021 -303.929 -309.79%
2022 -374.929 18.94%
2023 -703.451 46.7%
2024 -480.252 -46.48%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

DNA Brands, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 -1.612
2008 -616 -161.53%
2009 -1.197 48.49%
2010 -146.440 99.18%
2011 -69.888 -109.53%
2012 -47.789 -46.25%
2013 -12.256 -289.95%
2015 -15 -81600%
2016 -11 -36.36%
2017 -28 59.26%
2017 -11 -170%
2018 -16 33.33%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

DNA Brands, Inc. Free Cashflow
Year Free Cashflow Growth
2007 -27.000
2008 -22.343 -20.84%
2009 -17.917 -24.7%
2010 -3.577.925 99.5%
2011 -2.885.668 -23.99%
2012 -1.600.137 -80.34%
2013 -1.867.581 14.32%
2015 689 271156.75%
2016 -43.889 101.57%
2017 -3.908 -1023.06%
2017 -107.595 96.37%
2018 -8 -1536971.43%
2019 -61.661 99.99%
2020 -1.095.464 94.37%
2021 -434.497 -152.12%
2022 -421.269 -3.14%
2023 4.335 9817.85%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

DNA Brands, Inc. Operating Cashflow
Year Operating Cashflow Growth
2007 -27.000
2008 -21.872 -23.45%
2009 -17.917 -22.07%
2010 -3.536.794 99.49%
2011 -2.885.668 -22.56%
2012 -1.600.137 -80.34%
2013 -1.867.581 14.32%
2015 689 271156.75%
2016 -43.889 101.57%
2017 -3.908 -1023.06%
2017 -107.595 96.37%
2018 -8 -1536971.43%
2019 -34.061 99.98%
2020 -1.095.464 96.89%
2021 -434.497 -152.12%
2022 -421.269 -3.14%
2023 4.335 9817.85%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

DNA Brands, Inc. Capital Expenditure
Year Capital Expenditure Growth
2007 0
2008 471 100%
2009 0 0%
2010 41.131 100%
2011 0 0%
2012 0 0%
2013 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2017 0 0%
2018 0 0%
2019 27.600 100%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

DNA Brands, Inc. Equity
Year Equity Growth
2007 1.143
2008 -17.345 106.59%
2009 -53.251 67.43%
2010 -2.461.338 97.84%
2011 -3.577.155 31.19%
2012 -4.727.980 24.34%
2013 -2.564.899 -84.33%
2015 -1.644.493 -55.97%
2016 -1.607.665 -2.29%
2017 -1.807.540 11.06%
2017 -1.710.011 -5.7%
2018 -2.430.455 29.64%
2019 -2.551.076 4.73%
2020 -1.674.648 -52.34%
2021 -1.491.977 -12.24%
2022 -2.586.259 42.31%
2023 -3.380.301 23.49%
2024 -3.639.701 7.13%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

DNA Brands, Inc. Assets
Year Assets Growth
2007 26.648
2008 14.765 -80.48%
2009 357 -4035.85%
2010 493.105 99.93%
2011 372.490 -32.38%
2012 316.673 -17.63%
2013 523.591 39.52%
2015 2.190 -23808.26%
2016 63.401 96.55%
2017 70.806 10.46%
2017 47.055 -50.47%
2018 103.291 54.44%
2019 49.170 -110.07%
2020 1.051.448 95.32%
2021 1.110.019 5.28%
2022 257.697 -330.75%
2023 256.346 -0.53%
2024 257.359 0.39%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

DNA Brands, Inc. Liabilities
Year Liabilities Growth
2007 25.505
2008 32.110 20.57%
2009 53.608 40.1%
2010 2.954.443 98.19%
2011 3.949.645 25.2%
2012 5.044.653 21.71%
2013 3.088.490 -63.34%
2015 1.646.683 -87.56%
2016 1.671.066 1.46%
2017 1.878.346 11.04%
2017 1.757.066 -6.9%
2018 2.533.746 30.65%
2019 2.600.246 2.56%
2020 2.726.096 4.62%
2021 2.601.996 -4.77%
2022 2.843.956 8.51%
2023 3.636.647 21.8%
2024 3.897.061 6.68%

DNA Brands, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-0.08x
Price To Sales Ratio
0x
POCF Ratio
16.92
PFCF Ratio
39.14
Price to Book Ratio
-0.02
EV to Sales
0
EV Over EBITDA
-5.03
EV to Operating CashFlow
712.98
EV to FreeCashFlow
712.98
Earnings Yield
-12.73
FreeCashFlow Yield
0.03
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.01
Graham NetNet
-0.01

Income Statement Metrics

Net Income per Share
-0
Income Quality
-0.01
ROE
0.28
Return On Assets
-3.67
Return On Capital Employed
0.14
Net Income per EBT
1
EBT Per Ebit
1.9
Ebit per Revenue
0
Effective Tax Rate
0.18

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.6
Return on Tangible Assets
-3.67
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
-0
Shareholders Equity per Share
-0
Interest Debt per Share
0
Debt to Equity
-0.81
Debt to Assets
11.5
Net Debt to EBITDA
-4.76
Current Ratio
0.01
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-3869701
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
17.22

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

DNA Brands, Inc. Dividends
Year Dividends Growth

DNA Brands, Inc. Profile

About DNA Brands, Inc.

DNA Brands, Inc. provides energy drinks. It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. The company markets its products for retailers, restaurants, bars, and clubs. DNA Brands, Inc. also owns TokenTalk.io, an advisory firm for companies looking to raise money through an ICO. The company is based in Fort Lauderdale, Florida.

CEO
Mr. Adrian Mckenzie Patasar
Employee
1
Address
6245 N. Federal Highway
Fort Lauderdale, 33308

DNA Brands, Inc. Executives & BODs

DNA Brands, Inc. Executives & BODs
# Name Age
1 Mr. Andrew Ferrin
Chief Operating Officer
70
2 Mr. Howard Ullman
President
70
3 Mr. Adrian Mckenzie Patasar
Chief Executive Officer
70

DNA Brands, Inc. Competitors